EBM BLS: Patients on Long Term Oral Anticoagulation Who Received Low Dose Aspirin for Chronic Coronary Syndrome Had A Higher Risk of Major Bleeding and Death | Synapse
June 3, 2026
EBM BLS: Patients on Long Term Oral Anticoagulation Who Received Low Dose Aspirin for Chronic Coronary Syndrome Had A Higher Risk of Major Bleeding and Death
Key Points
The aim is to evaluate the risk of major bleeding and death among patients on long-term oral anticoagulation who also receive low dose aspirin for chronic coronary syndrome.
Randomized trial with patients on long-term oral anticoagulation therapy.
Primary outcomes included rates of major bleeding and mortality.
Patients receiving low dose aspirin showed a significantly higher rate of major bleeding (event rate X%) compared to those not receiving aspirin (event rate Y%).
Increased mortality risk was also observed, with an HR of Z (95% CI: A-B, p-value: C).